The Nicotine Replacement Therapy (NRT) Market has experienced substantial growth, valued at USD 69 billion in 2023. Projections indicate a significant increase, with expectations set to reach USD 234.13 billion by 2031. This growth reflects the rising awareness about the health hazards associated with smoking and the increasing adoption of smoking cessation therapies like NRT to curb nicotine dependence. With an anticipated compound annual growth rate (CAGR) of 16.5% over the forecast period from 2024 to 2031, the market is poised for rapid expansion, driven by factors such as government initiatives to reduce smoking rates, advancements in NRT formulations, and growing consumer inclination towards healthier lifestyles.